Name: 歐盟和世衛組織聯手為貧困國家接種疫苗。 (EU, WHO team up to vaccinate poorer countries)
Uploaded: 2021-02-11T21:35:40.000Z
Duration: 1 min 43 s

程度副詞

the European Union and the World Health Organization will spend €40 million just under $50 million over the next three years to ensure better access to covert 19 vaccines in poor countries in the region.

歐洲聯盟和世界衛生組織將花費 4000 萬歐元只是低於 5000 萬美元在未來三年，以確保更好地獲得祕密 19 疫苗在該地區的貧窮國家。

The W H O Regional director for Europe Huns Clogger, told a virtual news briefing on Thursday that Armenia, Azerbaijan, Belarus, Georgia, Moldova and Ukraine will benefit from the initiative, which focuses on readiness, information, campaigns, supplies and health worker training.

W H O歐洲區域主任Huns Clogger週四在虛擬新聞發佈會上表示，亞美尼亞、阿塞拜疆、白俄羅斯、格魯吉亞、摩爾多瓦和烏克蘭將從該倡議中受益，該倡議的重點是準備、資訊、運動、供應和衛生工作者培訓。

At this point, the overwhelming majority off European countries remain vulnerable.

在這一點上，絕大多數歐洲國家仍然是脆弱的。

Right now it's a thin line between the hope of a vaccine and a false sense of security.

現在是在疫苗的希望和虛假的安全感之間的一條細線。

Based on information from 29 out off the 37 countries currently vaccinating in the European region today, 7.8 million people have completed their immunization Siri's that is equivalent toe on Lee, 1.5% off the population off those 29 countries.

根據目前歐洲地區37個疫苗接種國家中29個國家的資料，目前已有780萬人完成了免疫接種Siri的，相當於趾上李，1.5%的人口關這29個國家。

The two dose AstraZeneca covert 19 vaccine, developed with Oxford University, had been clouded by doubts after a small study showed it was less effective at preventing mild or moderate disease with the fast spreading South African variant of the virus.

與牛津大學合作開發的兩劑阿斯利康隱蔽19號疫苗，在一項小規模研究顯示它在預防輕度或中度疾病與快速傳播的南非變種病毒的效果較差後，曾被疑慮籠罩。

 While the variant waas off particular concern, it was not yet widespread in the region, but needs to be monitored carefully. 

雖然這種變異體引起了人們的特別關注，但它還沒有在該地區廣泛流行，但需要仔細監測。